Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Association between lupus psychosis and anti-ribosomal P protein antibodies.
- E. Bonfá, S. J. Golombek, +4 authors K. Elkon
- Medicine
- The New England journal of medicine
- 30 July 1987
In 18 of 20 patients with psychosis secondary to systemic lupus erythematosus (SLE), autoantibodies to ribosomal P proteins were detected by immunoblotting and measured with a new radioimmunoassay… Expand
Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study
Raynaud phenomenon occurs in more than 90% of patients with systemic sclerosis. In these patients the digital arteries and precapillary arterioles show marked fibrosis of the intima and luminal… Expand
Male lupus: retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature.
- L. D. Kaufman, J. Gómez-Reino, M. Heinicke, P. Gorevic
- Medicine
- Seminars in arthritis and rheumatism
- 1 February 1989
In conclusion, in a review of 52 male lupus patients we found an increased incidence of thrombocytopenia and renal disease without any other notable differences in clinical, laboratory, or… Expand
Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia.
- G. Fricchione, L. D. Kaufman, B. Gruber, M. Fink
- Medicine
- The American journal of medicine
- 1 April 1990
The Eosinophilia-Myalgia Syndrome: Status of 205 Patients and Results of Treatment 2 Years after Onset
- P. A. Hertzman, D. Clauw, +6 authors T. Pincus
- Medicine
- Annals of Internal Medicine
- 1 June 1995
In the fall of 1989, an outbreak of eosinophilia and severe myalgia was recognized. This syndrome, associated with the use of l-tryptophan, became known as the eosinophilia-myalgia syndrome [1, 2].… Expand
The spectrum of eosinophilic myositis. Clinical and immunopathogenic studies of three patients, and review of the literature.
- L. D. Kaufman, G. Kephart, +4 authors G. Gleich
- Medicine
- Arthritis and rheumatism
- 1993
Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: a spectrum of sclerodermatous skin disease.
- L. D. Kaufman, R. Seidman, M. E. Phillips, B. Gruber
- Medicine
- Journal of the American Academy of Dermatology
- 1 December 1990
The natural history of the clinical and pathologic features of skin disease was reviewed prospectively in 30 patients with the L-tryptophan-associated eosinophilia-myalgia syndrome. Overall,… Expand
Effects of commonly prescribed nonsteroidal anti-inflammatory drugs on thyroid hormone measurements.
- A. Bishnoi, H. E. Carlson, B. Gruber, L. D. Kaufman, J. Bock, K. Lidonnici
- Medicine
- The American journal of medicine
- 1 March 1994
PURPOSE
To assess the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on thyroid function tests.
PATIENTS AND METHODS
Eighty-nine patients receiving NSAIDs and 22 control subjects not… Expand
The expanding clinical spectrum of multisystem disease associated with eosinophilia.
- L. D. Kaufman, G. Gleich
- Medicine
- Archives of dermatology
- 1 February 1997
THE SPECTRUM of disorders characterized by peripheral blood and/or tissue eosinophilia is diverse and heterogeneous. The relative paucity of these diseases has limited the ability to better define… Expand
Late cutaneous Lyme disease: acrodermatitis chronica atrophicans.
- L. D. Kaufman, B. Gruber, M. E. Phillips, J. Benach
- Medicine
- The American journal of medicine
- 1 June 1989
Acrodermatitis chronica atrophicans (ACA) is a chronic skin disorder characterized in its initial stages by an edematous infiltration that progresses to an atrophic lesion resembling localized… Expand